Shares of Galena Biopharma (GALE) are up 5% after the company announced that it has launched its anti-nausea drug known as Zuplenz . Zuplenz is an oral soluble film that helps reduce nausea and vomiting in patients with:
Zuplenz is a bioequivalent to odanestron — a similar product that also reduces nausea and vomiting. The drug product from Galena is now available worldwide and will be available at two dose levels, 4 mg and 8 mg. The benefits, as per the press release Galena released today:
Zuplenz technology uses a type of FarmFilm technology that allows the soluble film to dissolve in the patient's mouth. The film dissolves in about 10 seconds or less.
